Pfizer’s Tolterodine Tartrate Extended-Release Capsules are available in a 2mg and 4mg strength in 30-, 90-, and 500-count bottles. For more information call (888) 838-2872 or visit TevaGenerics ...

Pfizer sued Impax in 2008, claiming it infringed three patents in applying for U.S. Food and Drug Administration approval to copy its extended-release capsules.

Teva Pharmaceutical is shipping out a new product. The company announced it has launched the authorized generic form of Pfizer 's Detrol LA on the U.S. market. The drug will be sold in both two ...

Patients treated with DETROL® LA experienced a 77 percent reduction in weekly urge incontinence episodes, as compared to 51 percent for those receiving placebo. Patients treated with DETROL® LA ...

Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release (ER) Capsules, 2 mg and 4 mg.

JERUSALEM-- (BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the launch of the Authorized Generic of Detrol®* LA (tolterodine tartrate extended-release capsules ...

Pfizer announced, in a Sept. 7, 2012, press release, that it has settled its litigation against Mylan and its subsidiary, Mylan Pharmaceuticals, regarding Pfizer’s patents covering Detrol LA ...

Pfizer Sues Impax for Infringing Detrol Patents By Reuters March 5, 20083:06 PM PSTUpdated March 5, 2008 ...

WALTHAM, Mass., April 3, 2008 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's effect ...

Of the 1,712 patients enrolled in this 12-week, randomized, double-blinded, placebo-controlled superiority study, 1,697 were randomized to receive either Toviaz 8 mg (n=679), Detrol LA 4 mg (n=684 ...